Literature DB >> 2203591

Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.

H M Moutsopoulos1, L V Zerva.   

Abstract

Antibodies to Ro (SSA) and La (SSB) cellular ribonucleoprotein complexes are found in the circulation of patients with Sjögren's syndrome (SS), mainly in those with the primary form of the syndrome. Their presence is associated with long disease duration, earlier disease onset, parotid gland enlargement, systemic manifestations and also with hypergammaglobulinemia, rheumatoid factors and monoclonal type II cryoglobulins. While anti-Ro (SSA) antibodies are not specific for SS, anti-La (SSB) antibodies seem to be specific. Studies of HLA class II molecules in Ss patients with and without these antibodies have shown that their production is under genetic control. Finally, there is no conclusive evidence relating pathogenetically these autoantibodies to tissue destruction in SS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203591     DOI: 10.1007/bf02205560

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Epitope specificity of anti-La antibodies from patients with Sjögren's syndrome.

Authors:  E W St Clair; N Talal; H M Moutsopoulos; A Ballester; L Zerva; J D Keene; D S Pisetsky
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

2.  Genetic differences between primary and secondary sicca syndrome.

Authors:  H M Moutsopoulos; D L Mann; A H Johnson; T M Chused
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

3.  Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus.

Authors:  P J Maddison; M Reichlin
Journal:  Arthritis Rheum       Date:  1979-08

4.  Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.

Authors:  E L Alexander; F C Arnett; T T Provost; M B Stevens
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

5.  Primary biliary cirrhosis associated with Sjögren's syndrome: evidence for circulating and tissue-deposited Ro/anti-Ro immune complexes.

Authors:  E Penner; M Reichlin
Journal:  Arthritis Rheum       Date:  1982-10

6.  Serological profiles in subgroups of patients with Sjögren's syndrome.

Authors:  M N Manoussakis; A G Tzioufas; P J Pange; H M Moutsopoulos
Journal:  Scand J Rheumatol Suppl       Date:  1986

7.  Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells.

Authors:  J P Hendrick; S L Wolin; J Rinke; M R Lerner; J A Steitz
Journal:  Mol Cell Biol       Date:  1981-12       Impact factor: 4.272

8.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

Authors:  J B Harley; M Reichlin; F C Arnett; E L Alexander; W B Bias; T T Provost
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

9.  Molecular analysis of the 60-kDa human Ro ribonucleoprotein.

Authors:  S L Deutscher; J B Harley; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression.

Authors:  R W Wilson; T T Provost; W B Bias; E L Alexander; D W Edlow; M C Hochberg; M B Stevens; F C Arnett
Journal:  Arthritis Rheum       Date:  1984-11
View more
  7 in total

1.  Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?

Authors:  Veli Yazisiz; Gokhan Arslan; Irem Hicran Ozbudak; Sema Turker; Funda Erbasan; Ali Berkant Avci; Omer Ozbudak; Ender Terzioglu
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

Review 2.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

3.  Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.

Authors:  Norma Nardi; Pilar Brito-Zerón; Manuel Ramos-Casals; Sira Aguiló; Ricard Cervera; Miguel Ingelmo; Josep Font
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

4.  Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus.

Authors:  Márcio Veronesi Fukuda; Simone Chinwa Lo; Cláudia Salvini de Almeida; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

5.  Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients.

Authors:  Yun Zhao; Ya Li; Li Wang; Xiao-Feng Li; Ci-Bo Huang; Guo-Chun Wang; Xue-Wu Zhang; Zhuo-Li Zhang; Xiao Zhang; Wei-Guo Xiao; Lie Dai; Yong-Fu Wang; Shao-Xian Hu; Hong-Bin Li; Lu Gong; Bin Liu; Ling-Yun Sun; Miao-Jia Zhang; Xuan Zhang; Yong-Zhe Li; De-Shun Du; Shun-Hua Zhang; Yuan-Yuan Sun; Feng-Chun Zhang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases.

Authors:  Damien Sène; Patrice Cacoub; François-Jérôme Authier; Julien Haroche; Alain Créange; David Saadoun; Zahir Amoura; Pierre-Jean Guillausseau; Jean-Pascal Lefaucheur
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

7.  Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial.

Authors:  James Posada; Saba Valadkhan; Daniel Burge; Kristen Davies; Jessica Tarn; John Casement; Kerry Jobling; Peter Gallagher; Douglas Wilson; Francesca Barone; Benjamin A Fisher; Wan-Fai Ng
Journal:  Arthritis Rheumatol       Date:  2020-11-22       Impact factor: 15.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.